Publications

5102 Results

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Authors
S Adams;M Othus;S Patel;K Miller;R Chugh;S Schuetze;M Chamberlin;B Haley;A Storniolo;K Cawley;M Reddy;S Anderson;C Zimmerman;A O'Dea;M Mirshahidi;J Ahnert;F Brescia;O Hahn;J Raymond;D Biggs;M Thompson;R Connolly;E Sharon;L Korde;R Gray;E Mayerson;M Plets;CD Blanke;YK Chae;R Kurzrock
Journal / Conference
Clinical Cancer Research, Jan 15;28(2):271-278
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34716198
PMC
PMC8776596
Study Number(s)
S1609

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Authors
H Arai;A Elliott;J Millstein;J Xiu;F-S Ou;F Innocenti;J Wang;F Battaglin;P Jayachandran;N Kawanishi;S Soni;W Zhang;D Sohal;R Goldberg;M Hall;A Scott;M Khushman;J Hwang;E Lou;B Weinberg;A Lockhart;A Shields;J Abraham;D Magee;P Stafford;J Zhang;A Venook;A Venook;W Korn;H-J Lenz
Journal / Conference
Oncogene Jan;41(2):260-267
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID34728807
PMC
PMC8738154
Study Number(s)
CTSU/C80405

Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Authors
C Chau;C Till;D Price;P Goodman;M Neuhouser;M Pollak;I Thompson;W Figg
Journal / Conference
Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
Year
2022
Research Committee(s)
Cancer Control
PMID
PMID34889205
PMC
PMC8776589
Study Number(s)
SWOG-9217

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

Authors
V Shankaran;J Unger;A Darke;J Suga;J Wade;P Kourlas;S Chandana;M O'Rourke;S Satti;D Liggett;D Hershman;S Ramsey
Journal / Conference
Journal of the National Cancer Institute Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
Year
2022
Research Committee(s)
Cancer Care Delivery
PMID
PMID34981117
PMC
PMC8902339
Study Number(s)
S1417CD

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

Authors
B Darst;R Hughley;A Pfennig;U Hazra;C Fan;P Wan;X Sheng;E Klein;P Goodman;I Thompson;T Rebbeck;D Conti;C Haiman
Journal / Conference
European Urology Jan 11;S0302-2838(21)02271-5. doi: 10.1016/j.eururo.2021.12.023. Online ahead of print
Year
2022
Research Committee(s)
Cancer Control and Prevention and Epidemiology
PMID
PMID35031163
Study Number(s)
S0000, SWOG-9217

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922

Authors
M Overman;K Guthrie;M Salem;K Pedersen;A Kalyan;S Bellasea;P Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S1922

Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104

Authors
H Soares;K Guthrie;S Ahmad;M Washington;B Ramnaraign;N Raj;C Seigel;S Bellasea;E Chiorean;A Dasari;J Strosberg;C Eng;PA Philip
Journal / Conference
ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
Year
2022
Research Committee(s)
Gastrointestinal
Study Number(s)
S2104

Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation

Authors
J Xu;K Guertin;N Gaddis;A Agler;R Parker;J Feldman;A Kristal;K Arnold;P Goodman;C Tangen;D Hancock;P Cassano
Journal / Conference
American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
Year
2022
Research Committee(s)
Prevention and Epidemiology
PMID
PMID35040869
Study Number(s)
S0000C

SWOG 1318: A Phase 2 Trial of Blinatumomab Followed by POMP Maintenance in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

Authors
A Advani;A Moseley;K O'Dwyer;B Wood;M Fang;M Wieduwilt;I Aldoss;J Park;R Klisovic;M Baer;W Stock;R Bhave;M Othus;R Harvey;C Willman;M Litzow;R Stone;E Sharon;H Erba
Journal / Conference
Journal of Clinical Oncology Feb 14;JCO2101766. doi: 10.1200/JCO.21.01766. Online ahead of print.
Year
2022
Research Committee(s)
Leukemia
PMID
PMID35157496
Study Number(s)
S1318